Seelos Therapeutics to Participate at the Jefferies 2019 Global Healthcare Conference in NYC

20:00 EDT 15 Apr 2019 | Globe Newswire

NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a clinical-stage biopharmaceutical company, announced today that they will present and host 1x1 and small group meetings at the Jefferies 2019 Global Healthcare Conference taking place June 4-7 at the Grand Hyatt in New York City. Chairman, Founder, and CEO Raj Mehra, PhD and Dr. Tim Whitaker, Seelos’ Head of Research and Development, will present and host the meetings.

About Seelos Therapeutics:

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company’s robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.

For more information, please visit our website:, the content of which is not incorporated herein by reference.

Contact Information:

Anthony Marciano
Head of Corporate Communications
Seelos Therapeutics, Inc.
(646) 293 2136

Seelos_full logo and icon color.jpg


More From BioPortfolio on "Seelos Therapeutics to Participate at the Jefferies 2019 Global Healthcare Conference in NYC"

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...